CCI clears Kotak Special Situations Fund investment in Biocon Biologics Ruchika Sharma14 Aug 2023 7:00 AMThe combination relates to the acquirer (Kotak Special Situations Fund) proposing to purchase certain equity shares in the target (Biocon Biologics).
Ipca Labs buys 33.38 percent stake in Unichem for over Rs 945 crore Ruchika Sharma5 Aug 2023 7:00 AMNew Delhi: Ipca Laboratories on Wednesday said it has completed the acquisition of a 33.38 per cent stake in Unichem for Rs 945.35 crore.Last...
CCI approves acquisition of 59.38 percent stake in Unichem Labs by Ipca Labs Ruchika Sharma29 July 2023 7:00 AMNew Delhi: The Competition Commission of India (CCI) approves the proposed combination involving acquisition of shareholding up to 59.38% of Unichem...
Biocon Biologics-Edelweiss deal cleared by CCI Ruchika Sharma11 May 2023 7:00 AMThe deal has been cleared under the green channel route.
Cipla, JB Chemicals dragged to court for alleged infringement of Vifor FCM patent Farhat Nasim9 May 2023 11:30 AMNew Delhi: Cipla Ltd and J B Chemicals and Pharmaceuticals have been embroiled in a court case as Swiss drug firm Vifor International moves Delhi High...
CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda Ruchika Sharma21 April 2023 6:45 AMNew Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of...
CCI approves proposed deal of Bharat Biotech International to acquire Eastman Exports shares Ruchika Sharma6 Dec 2022 6:09 AM"Given that there are no horizontal overlaps, vertical and/or complementary links between the activities of the BBIL (including its affiliates) and...
Anti-trust regulator CCI clears Abu Dhabi Investment Authority minority stake acquisition in Intas Pharma Ruchika Sharma11 Oct 2022 5:45 AMNew Delhi: Anti-trust regulator Competition Commission of India (CCI) has cleared Platinum Owl's acquisition of a minority stake in Intas...
CCI approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures Ruchika Sharma14 Aug 2022 5:30 AMDeals beyond certain thresholds require approval from CCI, which keeps a tab on anti-competitive practices in the market place.
CCI nod to acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings (JVCO) Ruchika Sharma15 Jun 2022 8:45 AMNew Delhi: The Competition Commission of India (CCI) approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings...
CCI approves Serum Institute Life Sciences-Biocon Biologics deal Medical Dialogues Bureau19 May 2022 9:42 AMNew Delhi: The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies...
CCI approves acquisition of minority stake of BDR Pharma by Multiples Private Equity Fund III, others Ruchika Sharma19 April 2022 9:13 AMThe proposed combination relates to the acquisition of a minority stake by Multiples Fund III and Financial Investors in the Target.
